Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 166
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the reduction in hemoglobin A1C (A1C) for participants taking saxagliptin in combination with metformin immediate release (IR) versus metformin IR alone.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Saxagliptin plus metformin IR intervention 2: Placebo plus metformin IR
Intervention descriptions: intervention 1: Tablets, Oral, 2.5 mg, Twice daily, 12 weeks intervention 2: Tablets, Oral, Placebo, Twice daily, 12 weeks

Protocol document: